Titre:
  • CD73 promotes resistance to HER2/ErbB2 antibody therapy
Auteur:Turcotte, Martin; Joensuu, Heikki; Kellokumpu-Lehtinen, Pirkko-Liisa; Sotiriou, Christos; Smyth, Mark John; Stagg, John; Allard, David; Mittal, Deepak; Bareche, Yacine; Buisseret, Laurence; Jose, Vinu; Pommey, Sandra; Delisle, Vincent; Loi, Sherene
Informations sur la publication:Cancer research, 77, 20, page (5652-5663)
Statut de publication:Publié, 2017-10
Sujet CREF:Cancérologie
MeSH keywords:5'-Nucleotidase -- immunology
Animals
Antibodies, Monoclonal -- immunology -- physiology
Antigens, CD -- immunology
Antigens, Neoplasm -- immunology
Breast Neoplasms -- immunology -- pathology -- therapy
Cell Line, Tumor
Disease Models, Animal
Drug Resistance, Neoplasm
Female
GPI-Linked Proteins -- immunology
Humans
Mice
Mice, Inbred BALB C
Mice, Transgenic
Molecular Targeted Therapy
Random Allocation
Receptor, ErbB-2 -- immunology
Signal Transduction
Tetraspanins -- immunology
Trastuzumab -- immunology -- pharmacology
Note générale:SCOPUS: ar.j
Langue:Anglais
Identificateurs:urn:issn:0008-5472
info:doi/10.1158/0008-5472.CAN-17-0707
info:pii/0008-5472.CAN-17-0707
info:scp/85031419069
info:pmid/28855210